These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Telomeres and telomerase: a dual role in hepatocarcinogenesis. Satyanarayana A; Manns MP; Rudolph KL Hepatology; 2004 Aug; 40(2):276-83. PubMed ID: 15368430 [TBL] [Abstract][Full Text] [Related]
23. TP53-dependent chromosome instability is associated with transient reductions in telomere length in immortal telomerase-positive cell lines. Schwartz JL; Jordan R; Liber H; Murnane JP; Evans HH Genes Chromosomes Cancer; 2001 Mar; 30(3):236-44. PubMed ID: 11170280 [TBL] [Abstract][Full Text] [Related]
24. [Telomere dysfunction and telomerase: implications for human pathophysiology during ageing and chronic diseases]. Plentz RR; Rudolph KL Dtsch Med Wochenschr; 2006 Sep; 131(38):2087-90. PubMed ID: 16981080 [No Abstract] [Full Text] [Related]
25. Telomere, telomerase, tumorigenesis and therapy: an overview. Sen S; Dasgupta A; Roychudhuri A; Mittra B; Majumder HK Indian J Exp Biol; 1999 Sep; 37(9):839-42. PubMed ID: 10687276 [TBL] [Abstract][Full Text] [Related]
26. The disparity between human cell senescence in vitro and lifelong replication in vivo. Rubin H Nat Biotechnol; 2002 Jul; 20(7):675-81. PubMed ID: 12089551 [TBL] [Abstract][Full Text] [Related]
27. Telomeres and telomerase in leukaemia and lymphoma. Davison GM Transfus Apher Sci; 2007 Aug; 37(1):43-7. PubMed ID: 17766184 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease. Tárkányi I; Aradi J Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408 [TBL] [Abstract][Full Text] [Related]
29. Telomere instability and cancer. Londoño-Vallejo JA Biochimie; 2008 Jan; 90(1):73-82. PubMed ID: 17728038 [TBL] [Abstract][Full Text] [Related]
30. Introduction to telomeres and telomerase. Bibby MC Methods Mol Biol; 2002; 191():1-12. PubMed ID: 11951598 [No Abstract] [Full Text] [Related]
33. Simultaneous decrease of telomere length and telomerase activity with ageing of human amniotic fluid cells. Mosquera A; Fernández JL; Campos A; Goyanes VJ; Ramiro-Díaz J; Gosálvez J J Med Genet; 1999 Jun; 36(6):494-6. PubMed ID: 10874642 [No Abstract] [Full Text] [Related]
34. Telomeres, telomerase and cellular immortalization. Jones CJ Symp Soc Exp Biol; 2000; 52():135-48. PubMed ID: 12090003 [No Abstract] [Full Text] [Related]
35. Length control of human telomeres. de Lange T Cancer J Sci Am; 1998 May; 4 Suppl 1():S22-5. PubMed ID: 9619267 [No Abstract] [Full Text] [Related]
36. Senescence and immortalization: role of telomeres and telomerase. Shay JW; Wright WE Carcinogenesis; 2005 May; 26(5):867-74. PubMed ID: 15471900 [TBL] [Abstract][Full Text] [Related]
37. Effects of telomerase modulation in human hematopoietic progenitor cells. Zimmermann S; Glaser S; Ketteler R; Waller CF; Klingmüller U; Martens UM Stem Cells; 2004; 22(5):741-9. PubMed ID: 15342938 [TBL] [Abstract][Full Text] [Related]
38. Telomerase activation in human fibroblasts during escape from crisis. Montalto MC; Phillips JS; Ray FA J Cell Physiol; 1999 Jul; 180(1):46-52. PubMed ID: 10362016 [TBL] [Abstract][Full Text] [Related]